(Reuters) -Shares of Sarepta sank 36% before the bell on Tuesday after a trial for two gene-targeted therapies for a ...

Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

The owner of Gene & Georgetti, the iconic Chicago steak house, said she is being pushed out of her space at the Midway ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

The U.S. Food and Drug Administration has placed a clinical hold on Intellia Therapeutics' two late-stage trials testing an ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

Around the globe, heart disease remains one of the top causes of death. Once patients begin to suffer from serious heart ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...

Gene Simmons is a rock legend and a hard man to please, so when he says he loves this guitarist, you better believe that he ...

Beginning Wednesday, Nov. 5, the beloved riverside hangout will once again take on the identity of Gene’s Supper Club on the ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories that churn out a protein that is essentially the ...